| Home > Publications Database > Autophagy regulator ATG5 preserves cerebellar function by safeguarding its glycolytic activity. > print |
| 001 | 277313 | ||
| 005 | 20250323000912.0 | ||
| 024 | 7 | _ | |a 10.1038/s42255-024-01196-4 |2 doi |
| 024 | 7 | _ | |a pmid:39815080 |2 pmid |
| 024 | 7 | _ | |a altmetric:173037580 |2 altmetric |
| 037 | _ | _ | |a DZNE-2025-00376 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Tutas, Janine |0 P:(DE-2719)9002478 |b 0 |u dzne |
| 245 | _ | _ | |a Autophagy regulator ATG5 preserves cerebellar function by safeguarding its glycolytic activity. |
| 260 | _ | _ | |a [London] |c 2025 |b Springer Nature |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1740584111_16241 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Dysfunctions in autophagy, a cellular mechanism for breaking down components within lysosomes, often lead to neurodegeneration. The specific mechanisms underlying neuronal vulnerability due to autophagy dysfunction remain elusive. Here we show that autophagy contributes to cerebellar Purkinje cell (PC) survival by safeguarding their glycolytic activity. Outside the conventional housekeeping role, autophagy is also involved in the ATG5-mediated regulation of glucose transporter 2 (GLUT2) levels during cerebellar maturation. Autophagy-deficient PCs exhibit GLUT2 accumulation on the plasma membrane, along with increased glucose uptake and alterations in glycolysis. We identify lysophosphatidic acid and serine as glycolytic intermediates that trigger PC death and demonstrate that the deletion of GLUT2 in ATG5-deficient mice mitigates PC neurodegeneration and rescues their ataxic gait. Taken together, this work reveals a mechanism for regulating GLUT2 levels in neurons and provides insights into the neuroprotective role of autophagy by controlling glucose homeostasis in the brain. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Autophagy-Related Protein 5 |2 NLM Chemicals |
| 650 | _ | 7 | |a Atg5 protein, mouse |2 NLM Chemicals |
| 650 | _ | 7 | |a Glucose |0 IY9XDZ35W2 |2 NLM Chemicals |
| 650 | _ | 7 | |a Glucose Transporter Type 2 |2 NLM Chemicals |
| 650 | _ | 7 | |a Slc2a2 protein, mouse |2 NLM Chemicals |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Autophagy-Related Protein 5: metabolism |2 MeSH |
| 650 | _ | 2 | |a Autophagy-Related Protein 5: genetics |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Glycolysis |2 MeSH |
| 650 | _ | 2 | |a Autophagy |2 MeSH |
| 650 | _ | 2 | |a Cerebellum: metabolism |2 MeSH |
| 650 | _ | 2 | |a Purkinje Cells: metabolism |2 MeSH |
| 650 | _ | 2 | |a Glucose: metabolism |2 MeSH |
| 650 | _ | 2 | |a Glucose Transporter Type 2: metabolism |2 MeSH |
| 650 | _ | 2 | |a Mice, Knockout |2 MeSH |
| 700 | 1 | _ | |a Tolve, Marianna |0 P:(DE-2719)9002317 |b 1 |u dzne |
| 700 | 1 | _ | |a Özer-Yildiz, Ebru |b 2 |
| 700 | 1 | _ | |a Ickert, Lotte |0 0000-0003-2729-0928 |b 3 |
| 700 | 1 | _ | |a Klein, Ines |b 4 |
| 700 | 1 | _ | |a Silverman, Quinn |0 0000-0003-3660-3199 |b 5 |
| 700 | 1 | _ | |a Liebsch, Filip |0 0000-0002-0955-8065 |b 6 |
| 700 | 1 | _ | |a Dethloff, Frederik |0 0009-0002-1114-2621 |b 7 |
| 700 | 1 | _ | |a Giavalisco, Patrick |0 0000-0002-4636-1827 |b 8 |
| 700 | 1 | _ | |a Endepols, Heike |0 0000-0002-6166-4818 |b 9 |
| 700 | 1 | _ | |a Georgomanolis, Theodoros |b 10 |
| 700 | 1 | _ | |a Neumaier, Bernd |0 0000-0001-5425-3116 |b 11 |
| 700 | 1 | _ | |a Drzezga, Alexander |0 P:(DE-2719)2811239 |b 12 |
| 700 | 1 | _ | |a Schwarz, Guenter |0 0000-0002-2118-9338 |b 13 |
| 700 | 1 | _ | |a Thorens, Bernard |0 0000-0002-3738-0129 |b 14 |
| 700 | 1 | _ | |a Gatto, Graziana |0 0000-0002-4244-8925 |b 15 |
| 700 | 1 | _ | |a Frezza, Christian |0 0000-0002-3293-7397 |b 16 |
| 700 | 1 | _ | |a Kononenko, Natalia L |0 0000-0002-3425-6659 |b 17 |
| 773 | _ | _ | |a 10.1038/s42255-024-01196-4 |g Vol. 7, no. 2, p. 297 - 320 |0 PERI:(DE-600)2933873-6 |n 2 |p 297 - 320 |t Nature metabolism |v 7 |y 2025 |x 2522-5812 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/277313/files/DZNE-2025-00376.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/277313/files/DZNE-2025-00376.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:277313 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 0 |6 P:(DE-2719)9002478 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 1 |6 P:(DE-2719)9002317 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2811239 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-16 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a IF >= 20 |0 StatID:(DE-HGF)9920 |2 StatID |b NAT METAB : 2022 |d 2024-12-16 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT METAB : 2022 |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-16 |
| 915 | _ | _ | |a DEAL Nature |0 StatID:(DE-HGF)3003 |2 StatID |d 2024-12-16 |w ger |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-16 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-16 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-16 |
| 920 | 1 | _ | |0 I:(DE-2719)1011202 |k AG Boecker |l Positron Emissions Tomography (PET) |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1011202 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|